Results for tag: "Hydroxyprogesterone"

The Hydroxyprogesterone market is a subset of the larger uterine cancer drugs market. It is composed of drugs that contain hydroxyprogesterone, a synthetic form of the hormone progesterone. These drugs are used to treat uterine cancer, as well as other conditions such as endometriosis and polycystic ovary syndrome. Hydroxyprogesterone drugs are typically administered orally or intramuscularly, and can be used in combination with other drugs to treat more advanced stages of uterine cancer. Hydroxyprogesterone drugs are generally well-tolerated, with few side effects. However, they can cause some mild to moderate side effects, such as nausea, vomiting, and headaches. In addition, long-term use of hydroxyprogesterone drugs can increase the risk of certain types of cancer, such as breast cancer. Some companies in the Hydroxyprogesterone market include Pfizer, Merck, and Novartis. Other companies that produce hydroxyprogesterone drugs include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more